Britain advises alternative to Oxford/AstraZeneca COVID-19 vaccine for under-30s

Britain should give an alternative to Oxford/AstraZeneca's COVID-19 vaccine to under 30s where possible due to a "vanishingly" rare side effect of blood clots in the brain, Britain's vaccine advisory committee said on Wednesday.